Chief Medical Officer (CMO) – Radiopharmaceuticals

Chief Medical Officer (CMO) – Radiopharmaceuticals Location:

Remote (Europe or United States)

About the Company A rapidly growing diagnostic radiopharmaceutical company developing and commercialising next-generation molecular imaging agents across oncology and other high-value indications. With assets in early phase development, they are building a future for the best-in-class medical and scientific organisation to support worldwide adoption and patient impact.

The Opportunity They are seeking an accomplished

Chief Medical Officer (CMO)

to provide global medical, clinical, and scientific leadership across the diagnostic radiopharma portfolio. This is a pivotal executive role, reporting directly to the CEO and working closely with the Board, investors, and senior leadership team.

The CMO will shape medical strategy from clinical development through global launch and lifecycle management, ensuring scientific excellence, regulatory credibility, and strong engagement with key external stakeholders.

Key Responsibilities Define and lead the global medical and clinical strategy for diagnostic radiopharmaceutical programs from early development for future late developments and eventually commercialisation Provide executive oversight of clinical development, medical affairs, pharmacovigilance, and post-marketing activities Act as the company’s senior medical and scientific authority in interactions with regulators, HTA bodies, KOLs, and strategic partners Guide protocol design, imaging endpoints, dosimetry strategy, safety oversight, and regulatory submissions Build and lead a high-performing global medical organisation, including medical affairs, clinical science, and safety functions Support corporate strategy, portfolio evaluation, due diligence, and investor communications Represent the company at major scientific congresses and industry forums.

Candidate Profile MD with specialist training in nuclear medicine, radiology, oncology, or a closely related discipline Extensive experience in diagnostic radiopharmaceuticals/molecular imaging, ideally including global product launches Proven leadership at senior Medical Director, VP, or CMO level within biotech, pharma, or radiopharma organisations Deep understanding of regulatory pathways, GCP, medical governance, and post-approval medical affairs for diagnostics Strong strategic mindset with the ability to operate at both scientific and executive levels Excellent communication skills and credibility with regulators, investigators, and external partners Fluency in English required; additional languages are an advantage